Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Retinoblastoma 11Unspecified Adult Solid Tumor, Protocol Specific 8Solid Tumors 4Wilms Tumor 2Sarcoma 2Osteosarcoma 2Neuroblastoma 2Unspecified Childhood Solid Tumor, Protocol Specific 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Solid Tumours 1Solid Tumor 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinal Neoplasms 1Recurrence 1Pediatric Brain Tumor 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Germ Cell and Embryonal 1Malignant Solid Tumors 1Lymphoma 1Liver Neoplasms 1Kidney Neoplasms 1Hepatoblastoma 1Head and Neck Neoplasms 1Fibrosarcoma 1Eye Neoplasms 1

Interventions

pembrolizumab 14Injections 13Paclitaxel 10Nivolumab 10Docetaxel 9Cisplatin 9Capecitabine 9Bevacizumab 8toripalimab 7senaparib 7Fluorodeoxyglucose F18 7Cyclophosphamide 7tislelizumab 6atezolizumab 6Irinotecan 6Fluorouracil 6Gemcitabine 5fludarabine 4apatinib 4Oxaliplatin 4Leucovorin 4Ipilimumab 4spartalizumab 3pertuzumab 3olaparib 3camrelizumab 3Rifampin 3Radiosurgery 3Midazolam 3Itraconazole 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor × Topotecan × Other solid neoplasm × Clear all
NCT03987685 2022-02-16

Evaluate Oral Topotecan With HM30181A Monotherapy in Patients With Advanced Malignancies

Athenex, Inc.

Phase 1 Completed
10 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡